image_pdfimage_print
25 08, 2021

Spotlight on State: Arizona

This is part of a series of summaries that highlight notable legislation and initiatives in health policy and reform of all 50 states. Check back on The Source as we roll out additional states each week. See Arizona page. Arizona is active in promoting price transparency in health care. The state has some protections in place that address surprise billing for emergency services and services from out-of-network providers. This includes creating a solution for settling payment disputes between out-of-network providers and insurers by limiting patients’ liability and allowing for arbitration to settle disputes. The [...]

Spotlight on State: Arizona
3 08, 2021

New on The Source: Downloadable Chart of Merger Review Legal Authority for All 50 States

Newly available on the Source: our health policy research team compiled a user-friendly, downloadable Excel spreadsheet of all provider merger review authority for all 50 states, now on the Market Consolidation interactive key issue page. The detailed chart provides clickable citations of all statutes, regulations, and state authority for mergers, acquisitions, conversions, or changes in ownership of healthcare providers. The comprehensive spreadsheet allows side-by-side comparisons of the level of legal authority for each state to receive notice of impending transactions, review those transactions, and approve, conditionally approve, or disapprove them. It is conveniently organized [...]

New on The Source: Downloadable Chart of Merger Review Legal Authority for All 50 States
30 06, 2021

HB 2890 (see companion bill SB 1749)

Prescription drugs; upper payment limit: This article requires state-sponsored and state-regulated health plans and health programs to limit drug reimbursements and drug payments to not more than the board-established upper-payment limit. Health care providers who dispense and administer drugs to individuals in this state may not bill more than the upper-payment limit to the patient or the third-party payor without regard to whether the health plan chooses to reimburse the provider above the upper-payment limit.

HB 2890 (see companion bill SB 1749)
30 06, 2021

SB 1075 (replaced by HB 2119)

Health care insurance; amendments. Makes various changes to statute governing Health Care Insurers: Service Organizations 1. Applies statute relating to assignment of benefits to a hospital and medical service corporation. (Sec. 3) 2. Applies laws governing insurance company holding systems to Service Corporations. (Sec. 4) 3. Allows a corporation to pay any agent or employee any salary, compensation or emolument without preauthorization from the board of directors of the corporation. (Sec. 6) Health Care Services Organizations 4. Requires an HCSO to submit quarterly, rather than monthly, to the Department of Insurance and Financial Institutions, [...]

SB 1075 (replaced by HB 2119)
30 06, 2021

SB 1087

Pharmacy board; regulation: Durable medical equipment means technologically sophisticated medical equipment as prescribed by the board in rule that a patient or consumer may use in a home or residence and that may be a prescription-only device.

SB 1087
30 06, 2021

SB 1145

Telemedicine; physicians: Through telemedicine as defined in section 36-3601 with a clinical evaluation that is appropriate for the patient and the condition with which the patient presents.

SB 1145
30 06, 2021

SB 1170

Board of pharmacy; rulemaking authority: A pharmacist who is licensed pursuant to this chapter and who meets the requirements of this section may prescribe and administer oral fluoride varnish pursuant to rules adopted by the board. A pharmacist who is licensed pursuant to this chapter and who meets the requirements of this section may prescribe and dispense tobacco cessation drug therapies to a qualified patient. A pharmacist may not give or receive, either directly or indirectly, a payment, kickback, rebate, bonus or other remuneration for a referral to a dentist or physician.

SB 1170
Go to Top